openPR Logo
Press release

Endocrine Testing Market to Reach USD 22.3 Billion by 2035, Driven by Rising Hormonal Disorders, Automation, and AI-Enabled Diagnostics

10-01-2025 09:20 AM CET | Health & Medicine

Press release from: MarketGenics India Pvt. Ltd.

Endocrine Testing Market to Reach USD 22.3 Billion by 2035, Driven by Rising Hormonal Disorders, Automation, and AI-Enabled Diagno

Endocrine Testing Market to Reach USD 22.3 Billion by 2035, Driven by Rising Hormonal Disorders, Automation, and AI-Enabled Diagno

The global Endocrine Testing Market is valued at USD 11.5 billion in 2025 and is projected to reach USD 22.3 billion by 2035, growing at a CAGR of 6.2% during the forecast period. Growth is driven by the rising global burden of thyroid, diabetes, adrenal, and reproductive disorders, coupled with the adoption of automated and AI-powered testing platforms.

MarketGenics underscores the endocrine testing sector as a critical pillar of preventive healthcare and precision medicine, enabling early detection, continuous monitoring, and personalized treatment strategies across hospitals, clinics, and diagnostic labs.

Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Endocrine Testing Market Research Report: https://marketgenics.co/press-releases/endocrine-testing-market-51626

Recent Developments Shaping the Market
Quest Diagnostics Launches AI-Enhanced Thyroid Panel

In April 2025, Quest Diagnostics introduced an AI-driven thyroid panel designed for improved subclinical diagnosis of hypothyroidism and hyperthyroidism.

Roche Diagnostics Receives FDA Clearance for Elecsys Cortisol Assay

In March 2025, Roche secured FDA approval for its Elecsys cortisol assay, enhancing adrenal function diagnostics with high analytical precision.

DiaSorin Expands LIAISON XL Platform

In February 2025, DiaSorin added new thyroid and fertility hormone panels to its LIAISON XL platform, targeting adoption across Europe and Asia.

Market Forecast to 2035
The market is set to create an incremental opportunity of USD 10.8 billion over the decade.

North America will dominate, supported by advanced healthcare infrastructure, high disease prevalence, and strong insurance coverage for hormone testing.

Europe will grow steadily, driven by expanded fertility and thyroid testing programs.

Asia-Pacific will be the fastest-growing market, led by urbanization, sedentary lifestyles increasing endocrine disorders, and government-backed screening programs.

To know more about the Endocrine Testing Market - Download our Sample Report: https://marketgenics.co/download-report-sample/endocrine-testing-market-51626

Key Drivers, Restraints, and Opportunities
Driver - Rising Burden of Diabetes and Hormonal Disorders

According to the International Diabetes Federation, global diabetes cases are expected to rise from 537 million in 2023 to 643 million by 2030, fueling demand for glucose and insulin testing. Similarly, thyroid and reproductive hormone disorders continue to surge, increasing the need for regular endocrine assessments.

Restraint - High Cost of Advanced Testing Systems

Capital-intensive analyzers and expensive reagents restrict adoption in developing regions. Tier-2 and Tier-3 diagnostic centers face affordability challenges, limiting penetration of high-throughput endocrine testing.

Opportunity - Point-of-Care (POC) Endocrine Testing

Miniaturized diagnostic systems such as BioMérieux's VIDAS 3 platform are expanding POC hormone testing to outpatient clinics, pharmacies, and rural health centers, enabling faster, more accessible diagnostics.

Key Trend - Multiplex and AI-Powered Diagnostic Panels
AI-powered multiplex hormone testing is transforming endocrine diagnostics into predictive and precision-driven healthcare solutions.

In early 2025, Thermo Fisher Scientific partnered with Tempus AI to integrate multiplex endocrine kits with real-time cloud-based analytics, reducing diagnostic turnaround time by 25% in pilot U.S. hospitals.

Buy Now: https://marketgenics.co/buy/endocrine-testing-market-51626

Segmental Insights
Thyroid Function Tests Lead - Holding ~32% share in 2025, thyroid tests (T3, T4, TSH) remain the backbone of endocrine diagnostics due to widespread prevalence of thyroid disorders.

Glucose-Related Tests - Rising diabetes burden drives strong demand for insulin and C-peptide assays.

Reproductive Hormone Testing - Growing prevalence of PCOS and fertility-related conditions is accelerating adoption in both hospitals and fertility clinics.

Regional Highlights
North America: Dominates the market, supported by disease prevalence, advanced infrastructure, and insurance reimbursement.

Europe: Increasing adoption of fertility and thyroid hormone testing, supported by public health programs.

Asia-Pacific: Fastest growth due to government programs and rising lifestyle-related endocrine disorders.

Middle East & Africa: Gradual adoption, with growth tied to expansion of private diagnostic networks.

Competitive Landscape
The global endocrine testing market is moderately fragmented, with the top five players holding 64% share in 2025.

Tier 1 Leaders: Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Beckman Coulter (Danaher), Bio-Rad Laboratories.

Tier 2 Players: EUROIMMUN, IDS, BioMérieux, Thermo Fisher Scientific.

Competition is focused on automation, AI integration, and POC diagnostics, with major players launching high-throughput analyzers, multiplex panels, and AI-enhanced diagnostic tools.

Get a preview of our Endocrine Testing Market Playbook - your guide to GTM strategy, competitive intelligence, supplier dynamics, and Consumer Behavior Analysis: https://marketgenics.co/playbook/endocrine-testing-market-51626

Future Outlook
By 2035, endocrine testing will evolve into a precision-driven ecosystem, combining wearable biosensors, AI-powered predictive diagnostics, and decentralized POC platforms. These technologies will enable earlier detection, real-time monitoring, and personalized hormone therapies, fueling significant market growth.

The endocrine testing market is positioned to double in size, reaching USD 22.3 billion by 2035, cementing its role as a cornerstone of modern diagnostic healthcare.

Prominent Companies Operating in the Global Endocrine Testing Market
Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Beckman Coulter (Danaher), Bio-Rad Laboratories, BioMérieux, Thermo Fisher Scientific, EUROIMMUN, IDS, Quest Diagnostics, DiaSorin, and other emerging players.

About Us

MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.

We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.

Contact:

Mr. Debashish Roy

MarketGenics India Pvt. Ltd.

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617

Email: sales@marketgenics.co

Website: https://marketgenics.co

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endocrine Testing Market to Reach USD 22.3 Billion by 2035, Driven by Rising Hormonal Disorders, Automation, and AI-Enabled Diagnostics here

News-ID: 4205120 • Views:

More Releases from MarketGenics India Pvt. Ltd.

Contrast Media Market to Reach USD 14.1 Billion by 2035, Driven by Safer Formulations, Personalized Imaging, and Oncology Demand
Contrast Media Market to Reach USD 14.1 Billion by 2035, Driven by Safer Formula …
The global Contrast Media Market is valued at USD 6.6 billion in 2025 and is projected to grow to USD 14.1 billion by 2035, expanding at a CAGR of 7.2%. Rising imaging procedure volumes, coupled with demand for safer, low-toxicity formulations and growth in oncology and cardiovascular imaging, are propelling the market. MarketGenics highlights contrast media as a pivotal component of diagnostic imaging, where innovation is focused on low-dose, patient-specific agents
Dental Consumables Market to Reach USD 83.5 Billion by 2035, Driven by Implant Adoption, Digital Dentistry, and Cosmetic Demand
Dental Consumables Market to Reach USD 83.5 Billion by 2035, Driven by Implant A …
The global Dental Consumables Market is valued at USD 33.7 billion in 2025 and is projected to reach USD 83.5 billion by 2035, expanding at a CAGR of 8.6% during the forecast period. Growth is underpinned by rising demand for dental implants, accelerated adoption of digital dentistry (CAD/CAM and AI-enabled workflows), and a surge in cosmetic procedures such as whitening and veneers. MarketGenics positions dental consumables as a core enabler of
Edge Intelligence in IoT Healthcare Market to Reach USD 30.8 Billion by 2035, Driven by Real-Time Imaging, 5G, and On-Site AI Processing
Edge Intelligence in IoT Healthcare Market to Reach USD 30.8 Billion by 2035, Dr …
The global Edge Intelligence in IoT Healthcare Market is valued at USD 2.8 billion in 2025 and is projected to expand to USD 30.8 billion by 2035, registering a CAGR of 24.3% during the forecast period. The market's rapid acceleration is being driven by demand for latency-free clinical decision support, rising throughput at diagnostic imaging centers, the rollout of 5G, and strategic investments by hyperscalers and semiconductor vendors to bring
Electrophysiology Devices Market to Reach USD 38.3 Billion by 2035, Fueled by Rising AFib Cases, Minimally Invasive Procedures, and AI-Powered Mapping Technologies
Electrophysiology Devices Market to Reach USD 38.3 Billion by 2035, Fueled by Ri …
The global Electrophysiology Devices Market is valued at USD 11.2 billion in 2025 and is projected to reach USD 38.3 billion by 2035, expanding at a CAGR of 11.8% during the forecast period. Growth is driven by the surging incidence of atrial fibrillation (AFib) and other arrhythmias, the shift toward minimally invasive catheter-based procedures, and the integration of AI and advanced 3D mapping systems in cardiac electrophysiology. MarketGenics identifies electrophysiology as

All 5 Releases


More Releases for Testing

Global Testing Market Size - By Product Type(Terpene Profiling Testing,Heavy Met …
Market Overview and Report Coverage testing refers to the scientific analysis and evaluation of products to ensure their safety, potency, and compliance with regulatory standards. This process typically involves testing for profiles, contaminants, pesticides, heavy metals, and microbial residues. As becomes increasingly legalized for medicinal and recreational use across various regions, the demand for reliable testing services is growing, ensuring consumers receive high-quality
Sterility Testing Market, Sterility Testing Market Analysis, Sterility Testing M …
"According to the research report, the global synthetic biology market was valued at USD 13.07 billion in 2022 and is expected to reach USD 71.51 billion by 2032, to grow at a CAGR of 18.5% during the forecast period." Request Our Free Sample Report for Synthetic Biology Market Insights and Emerging Trends @ https://www.polarismarketresearch.com/industry-analysis/synthetic-biology-market/request-for-sample Report Overview Polaris Market Research, a leading global market research and consulting company, has recently published its latest report
Hemato Oncology Testing Market Global Hemato Oncology Testing Market, Hemato Onc …
Global Hemato Oncology Testing Market Research report is an in-depth study of the market Analysis. Along with the most recent patterns and figures that uncovers a wide examination of the market offer. This report provides exhaustive coverage on geographical segmentation, latest demand scope, growth rate analysis with industry revenue and CAGR status. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study
Test Automation Market | latest automation testing tools, automation testing too …
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Test Automation Market “ The “Test Automation Market” report provides analysis of the global test automation market for the period 2015–2025, wherein the years from 2017 to 2025 is the forecast period and 2016 is considered as the base year. The report precisely
Molecular Diagnostics Market Application On Infectious Disease Testing, Cardiova …
Worldwide Market Reports recently released “Global Molecular Diagnostics Market Research Report 2017” that centers around the latest developing trends and technologies in the Molecular Diagnostics Market having Five Years of forecast period from 2017 to 2022 and considering Market status study from 2017 to 2022. During the research, noteworthy data was collected in order to shape the research document and make it a valuable resource for managers, industry executives and other
Test Automation Market Quadruples by 2023; with a ~ 15.34 % of Whooping CAGR | C …
New Market Research Reports Title "Test Automation Market 2018" Has Been Added to Crystal Market Research Report database. Test Automation Market - Competitive Insights: The leading players in the market are Cognizant Corporation, IBM, Hewlett-Packard, Capgemini, Tata Consultancy Services and Infosys. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry. The Test